Ranbaxy Laboratories, the global generics company of the Daiichi-Sankyo Group, has signed a contract with NYK Logistics (UK) to handle all products destined for the UK market.
The operation is based at NYK Logistics’ pharmaceutical centre in Northampton, which provides supply chain systems for a number of major pharmaceutical customers.
The 175,000 sq ft facility provides temperature-controlled, high-security storage in line with the latest good distribution practice.
NYK’s healthcare distribution centre has a Manufacturers’ Import Authorisation from the Medicines & Healthcare Regulatory Authority (MHRA), as well as an MHRA Wholesale Dealer’s Licence and is therefore able to provide storage for products manufactured in Europe, as well as imports from outside the EU.
NYK receives all Ranbaxy’s product batch released and ready for sale throughout the UK.
NYK will handle 23 million packs per annum on behalf of Ranbaxy, destined for hospitals, pharmacies and wholesalers.
The pharmaceutical company is headquartered in Tokyo with revenues of £986 million ($1.6 billion).
